Oleksandr Ievglevskyi, Denis Zosen, Jordi Requena Osete, Joel C. Glover, Ragnhild Elisabeth Paulsen, Srdjan Djurovic, Elena Kondratskaya
{"title":"Human iPSC-Derived Spinal Cord Organoids – The First Electrophysiological Assessment of Neuronal Maturation","authors":"Oleksandr Ievglevskyi, Denis Zosen, Jordi Requena Osete, Joel C. Glover, Ragnhild Elisabeth Paulsen, Srdjan Djurovic, Elena Kondratskaya","doi":"10.1021/acschemneuro.5c00823","DOIUrl":null,"url":null,"abstract":"<p>The spinal cord exhibits a complex cytoarchitecture and\r\nneuronal\r\ncircuitry organization that challenges in vitro replication of its\r\nfunctional integrity. Here we employed a previously published protocol\r\nto generate spinal cord organoids (SCOs) from human-induced pluripotent\r\nstem cells (hiPSCs). We characterized phenotypic changes in functional\r\nneuronal properties in SCO neurons at early developmental stages (15–32\r\ndays in culture) using a quantitative electrophysiological approach.\r\nUsing the whole-cell patch-clamp technique to evaluate electrophysiological\r\nproperties, we found that SCO neurons exhibited progressive maturation,\r\nas evidenced by hyperpolarized resting membrane potentials, increased\r\ninward current amplitude, refined action potential kinetics, and the\r\nearly emergence of mature-type firing patterns. In particular, we\r\nshow that the spike frequency adaptation phenomenon, which prevails\r\nin motor neurons, appears at early stages of SCO neuron development.\r\nImmunohistochemical assessment confirmed the expression of key transcription\r\nfactors in motor neurons (ISLET1 and HB9) and immature spinal interneurons\r\n(LHX1/5 and PAX2). Collectively, our findings demonstrate that neurons\r\nin hiPSC-derived SCOs exhibit physiological differentiation, which\r\nis important for using SCOs to investigate human spinal cord development\r\nand advance translational research in CNS disorders and cell replacement\r\ntherapies.</p>","PeriodicalId":13,"journal":{"name":"ACS Chemical Neuroscience","volume":"17 16","pages":"3048–3057"},"PeriodicalIF":4.5000,"publicationDate":"2026-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Chemical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acschemneuro.5c00823","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/28 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The spinal cord exhibits a complex cytoarchitecture and
neuronal
circuitry organization that challenges in vitro replication of its
functional integrity. Here we employed a previously published protocol
to generate spinal cord organoids (SCOs) from human-induced pluripotent
stem cells (hiPSCs). We characterized phenotypic changes in functional
neuronal properties in SCO neurons at early developmental stages (15–32
days in culture) using a quantitative electrophysiological approach.
Using the whole-cell patch-clamp technique to evaluate electrophysiological
properties, we found that SCO neurons exhibited progressive maturation,
as evidenced by hyperpolarized resting membrane potentials, increased
inward current amplitude, refined action potential kinetics, and the
early emergence of mature-type firing patterns. In particular, we
show that the spike frequency adaptation phenomenon, which prevails
in motor neurons, appears at early stages of SCO neuron development.
Immunohistochemical assessment confirmed the expression of key transcription
factors in motor neurons (ISLET1 and HB9) and immature spinal interneurons
(LHX1/5 and PAX2). Collectively, our findings demonstrate that neurons
in hiPSC-derived SCOs exhibit physiological differentiation, which
is important for using SCOs to investigate human spinal cord development
and advance translational research in CNS disorders and cell replacement
therapies.
期刊介绍:
ACS Chemical Neuroscience publishes high-quality research articles and reviews that showcase chemical, quantitative biological, biophysical and bioengineering approaches to the understanding of the nervous system and to the development of new treatments for neurological disorders. Research in the journal focuses on aspects of chemical neurobiology and bio-neurochemistry such as the following:
Neurotransmitters and receptors
Neuropharmaceuticals and therapeutics
Neural development—Plasticity, and degeneration
Chemical, physical, and computational methods in neuroscience
Neuronal diseases—basis, detection, and treatment
Mechanism of aging, learning, memory and behavior
Pain and sensory processing
Neurotoxins
Neuroscience-inspired bioengineering
Development of methods in chemical neurobiology
Neuroimaging agents and technologies
Animal models for central nervous system diseases
Behavioral research